Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,626–7,650 of 7,816 matching trials · page 306 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan NCT00788047 Dextromethorphan; Dimebon + Dextromethorphan Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 14 | Pfizer INDUSTRY |
2009-03-09 |
|
MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology NCT00239759 Runs in: Canada; Germany; Greece; United States · 15 sites |
NA other |
COMPLETED | 2,000 | National Institute on Aging (NIA) NIH |
2009-02-25 |
|
Observational Study on Costs and Caregiver Burden in Alzheimer's Disease NCT00698165 Runs in: Spain; Sweden; United Kingdom; United States · 82 sites |
NA other |
COMPLETED | 2,400 | AstraZeneca INDUSTRY |
2009-02-20 |
|
Are Character Building Lessons Effective in Decreasing Bullying Behaviors? NCT00431470 Six classroom based character building education lessons Runs in: United States · 1 site |
NA other |
COMPLETED | 175 | Maimonides Medical Center OTHER |
2009-02-05 |
|
Ursodiol in Huntington's Disease NCT00514774 ursodiol; placebo Runs in: United States · 1 site |
PHASE1 other |
UNKNOWN | 21 | Oregon Health and Science University OTHER |
2009-02-05 |
|
A Pilot Study of Inflammatory Markers in Alzheimer's Disease NCT00715858 doxycycline; rifampin; placebo Runs in: Canada · 1 site |
PHASE3 other |
UNKNOWN | 21 | McMaster University OTHER |
2009-02-04 |
|
Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia? NCT00164970 Vitamin B12; folate Runs in: China · 1 site |
PHASE4 other |
COMPLETED | 166 | Chinese University of Hong Kong OTHER |
2009-02-03 |
|
Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects NCT00684710 PAZ-417; Placebo Runs in: Japan · 1 site |
PHASE1 other |
COMPLETED | 56 | Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY |
2009-01-30 |
|
Effects of a Complex Cognitive Training in Mild Cognitive Impairment and Mild Alzheimer's Disease NCT00544856 complex cognitive training |
NA other |
COMPLETED | 39 | Ludwig-Maximilians - University of Munich OTHER |
2009-01-29 |
|
Memory Imaging of Normal Aging NCT00315575 BOLD and Perfusion brain MRI Runs in: United States · 1 site |
NA other |
COMPLETED | 90 | National Institute on Aging (NIA) NIH |
2009-01-26 |
|
Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid NCT00692705 Radioligand (11C)AZD2995; Radioligand (11C)AZD2184 Runs in: Sweden · 1 site |
PHASE1 other |
COMPLETED | 13 | AstraZeneca INDUSTRY |
2009-01-23 |
|
Electrophysiologic Measures of Treatment Response in Alzheimer Disease NCT00018278 Aricept; Exelon; Nicoderm Patch Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | — | US Department of Veterans Affairs OTHER_GOV |
2009-01-21 |
|
Specific Interventions for Agitation in Alzheimer's Disease NCT00018291 Risperidone; Gabapentin Runs in: United States · 1 site |
NA other |
COMPLETED | — | US Department of Veterans Affairs OTHER_GOV |
2009-01-21 |
|
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen NCT00018343 estrogen Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | — | US Department of Veterans Affairs OTHER_GOV |
2009-01-21 |
|
Insulin, Neurogenetics and Memory in Alzheimer's Disease NCT00018382 rosiglitazone Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | — | US Department of Veterans Affairs OTHER_GOV |
2009-01-21 |
|
Gene-Environment Interactions in Alzheimer's Disease NCT00018473 Runs in: United States · 1 site |
NA other |
COMPLETED | — | US Department of Veterans Affairs OTHER_GOV |
2009-01-21 |
|
Family Health After Predictive Huntington Disease (HD) Testing NCT00075140 Mutation in the gene Runs in: United States · 1 site |
NA other |
COMPLETED | 422 | National Institute of Nursing Research (NINR) NIH |
2009-01-16 |
|
Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease NCT00006399 Donepezil; Estrogen; Progesterone Runs in: United States · 1 site |
PHASE2 symptomatic-cholinergic |
COMPLETED | 45 | National Center for Research Resources (NCRR) NIH |
2009-01-15 |
|
Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease NCT00188812 donepezil hcl Runs in: Canada · 1 site |
PHASE3 symptomatic-cholinergic |
COMPLETED | — | University Health Network, Toronto OTHER |
2009-01-12 |
|
Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD) NCT00675077 Far Infrared Radiation Runs in: Canada · 1 site |
PHASE1 other |
UNKNOWN | 5 | GAAD Medical Research Institute Inc. OTHER |
2009-01-05 |
|
Memantine Versus Donepezil in Early Stages of Alzheimer's Disease NCT00505167 Memantine; Donepezil Runs in: Spain · 3 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 64 | Hospital Miguel Servet OTHER |
2008-12-29 |
|
A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers. NCT00551772 SB-742457 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 12 | GlaxoSmithKline INDUSTRY |
2008-12-25 |
|
Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease NCT00285077 SR57667B Runs in: Canada; Denmark; Finland; France; Germany; South Africa; Sweden · 7 sites |
PHASE2 other |
COMPLETED | 390 | Sanofi INDUSTRY |
2008-12-23 |
|
Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. NCT00380302 AVE1625 Runs in: France; Italy; Netherlands; Sweden; United States · 5 sites |
PHASE1|PHASE2 other |
COMPLETED | 162 | Sanofi INDUSTRY |
2008-12-19 |
|
Effectiveness of the FearNot!v.2.0 Software in Reducing Bullying Victimisation Among Primary School Children NCT00597337 FearNot Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 1,129 | University of Warwick OTHER |
2008-12-18 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial